Global Pharma Reach Novacap is a global player with a presence across Europe, Asia, and America, serving 1000+ customers in 80+ countries. Sales opportunities exist in expanding internationally through contract development, manufacturing, and distribution partnerships with their pharmaceutical, cosmetics, food, and personal care segments.

Strategic Acquisitions Recent acquisition of PCI Synthesis strengthens capabilities in pharmaceutical synthesis and CDMO services. Target opportunities include expanded contract manufacturing, process development, and scale-up collaborations for complex APIs and specialty chemicals.

Diverse End Markets Strong positions in pharma, cosmetics & fragrances, food & feed, and personal care indicate cross-market demand for high-purity intermediates, active pharmaceutical ingredients, and specialty chemistries suitable for consumer-facing products and regulated industries.

Sustainability & CSR Committed to sustainable and responsible growth through CSR programs. Prospects exist for partnerships around green production, sustainability reporting, compliance expertise, and supply chain transparency which can appeal to customers prioritizing ESG criteria.

Innovation Footprint Extensive R&D units and 35 plants indicate capability for customized solutions, rapid scale-up, and tech-enabled product development. Opportunities include co-development projects, tailored formulations, and performance-driven collaborations for advanced specialties.